.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recently, Philips and Apollo Hospitals signed a Memorandum of Understanding (MoU) to enhance stroke and heart care across India. This strategic partnership aims to address the growing burden of cardiovascular and neurological diseases. Consequently, the collaboration will focus on technology-enabled pathways for faster diagnosis and intervention. Clinicians will benefit from integrated decision-making tools for complex, time-sensitive cases.
India reported approximately 1.25 million new stroke cases in 2021. This figure represents a significant increase compared to data from 1990. Additionally, cardiovascular diseases remain the leading cause of mortality in India. Therefore, the partnership prioritizes precision imaging and faster interventions. The goal is to reduce the \"door-to-needle\" time for stroke patients. Consequently, this focus could significantly improve survival rates during the critical \"golden hour.\"
The collaboration leverages advanced imaging and image-guided therapy. Specifically, the teams aim to optimize contrast usage and procedural accuracy in structural heart disease. Furthermore, streamlined workflows will likely enhance overall clinical efficiency. Roy Jakobs, CEO of Royal Philips, emphasized the need for data-driven, resilient care pathways. Similarly, Dr. Prathap C. Reddy noted that advanced technology is vital for scalable healthcare. Ultimately, this initiative seeks to deliver high-quality care to a larger patient population.
Q1: What are the primary focus areas of the Philips-Apollo collaboration?
The partnership specifically targets two clinical areas: structural heart disease management and stroke care workflows in India.
Q2: How will this initiative help stroke patients in India?
The initiative aims to accelerate imaging workflows and streamline patient pathways. This ensures interventions occur within the critical \"golden hour\" to improve clinical outcomes.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Philips and Apollo Hospitals sign an MoU to enhance stroke and structural heart disease management in India through advanced imaging and integrated care....
7 months ago
Red blood cell transfusion is critical in sickle cell disease management but brings significant immunological complexity, including alloimmunisation and iron overload. Extended RBC phenotyping and tailored protocols optimize clinical safety.
Today
Review the expanding spectrum of DICER1-associated gynecologic neoplasms, key morphologic hallmarks, and critical clinical surveillance protocols for young patients.
Today
A large UK Biobank study reveals that plasma proteomic signatures capture preclinical organ damage and improve multiorgan risk prediction across early CKM syndrome stages 0 to 2 beyond traditional PREVENT clinical models.
Today
A retrospective CBCT study reveals that superior TMJ space asymmetry correlates moderately with occipital condyle-atlas-axis asymmetry in unilateral TMJ osteoarthritis, highlighting an imaging correlate between jaw biomechanics and upper cervical alignment rather than a standalone diagnostic marker.
Today
A Bayesian multilevel meta-analysis reveals that aerobic training combined with moderate carbohydrate restriction modestly lowers HbA1c in type 2 diabetes. However, sparse data and very low certainty leave incremental benefits over exercise or diet alone unproven, highlighting the need for individualized care.
Today
